Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate

Clinical trial NCT07158398 · COMPLETED

Trial details

NCT number: NCT07158398
Sponsor: Deciphera Pharmaceuticals, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-10-31
Primary completion: 2025-12-08
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.